Sunday, September 20, 2026

KeyCorp Stock Falls By 28% In The Last 21 Sessions

KeyCorp Stock Falls By 28% In The Last 21 Sessions

(VIANEWS) - Shares of KeyCorp (NYSE: KEY) dropped by a staggering 28.84% in 21 sessions from $12.38 at 2023-04-19, to $8.81 at 14:14 EST on Thursday, after five consecutive sessions in a row of losses. NYSE is dropping 0.92% to $15,093.45, after three sequential sessions in a row of losses.

KeyCorp's last close was $9.53, 57.01% under its 52-week high of $22.17.

About KeyCorp

KeyCorp operates as the holding company for KeyBank National Association that provides various retail and commercial banking products and services in the United States. It operates in two segments, Consumer Bank and Commercial Bank. The company offers various deposits, investment products and services; and personal finance and financial wellness, student loan refinancing, mortgage and home equity, lending, credit card, treasury, business advisory, wealth management, asset management, investment, cash management, portfolio management, and trust and related services to individuals and small and medium-sized businesses. It also provides a suite of banking and capital market products, such as syndicated finance, debt and equity capital market products, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory, and public finance, as well as commercial mortgage loans comprising consumer, energy, healthcare, industrial, public sector, real estate, and technology loans for middle market clients. In addition, the company offers community development financing, securities underwriting, brokerage, and investment banking services. The company was founded in 1849 and is headquartered in Cleveland, Ohio.

Earnings Per Share

As for profitability, KeyCorp has a trailing twelve months EPS of $1.74.

PE Ratio

KeyCorp has a trailing twelve months price to earnings ratio of 5.06. Meaning, the purchaser of the share is investing $5.06 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.38%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is a negative 2.2% and a negative 20.4%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 16.1%, now sitting on 6.74B for the twelve trailing months.

Moving Average

KeyCorp's worth is way under its 50-day moving average of $15.47 and way under its 200-day moving average of $17.22.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Feb 26, 2023, the estimated forward annual dividend rate is 0.82 and the estimated forward annual dividend yield is 6.78%.

More news about KeyCorp (KEY).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com